Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022

Upgrades

See all analyst ratings upgrades.

Downgrades

See all analyst ratings downgrades.

Initiations

Capital One initiated coverage on IDEAYA Biosciences Inc IDYA with an Overweight rating. The price target for IDEAYA Biosciences is set to $29.00. IDEAYA Biosciences earned $0.04 in the third quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.09 and a 52-week-low of $8.14. IDEAYA Biosciences closed at $16.53 at the end of the last trading period.

Janney Montgomery Scott initiated coverage on Generac Holdings Inc GNRC with a Buy rating. The price target for Generac Hldgs is set to $160.00. For the third quarter, Generac Hldgs had an EPS of $1.75, compared to year-ago quarter EPS of $2.35. At the moment, the stock has a 52-week-high of $357.15 and a 52-week-low of $86.29. Generac Hldgs closed at $91.15 at the end of the last trading period.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Akili Inc AKLI. The price target seems to have been set at $2.00 for Akili. The stock has a 52-week-high of $37.58 and a 52-week-low of $0.99. At the end of the last trading period, Akili closed at $1.00.

See all analyst ratings initiations.